-
1
-
-
84897657812
-
-
Teflaro® Package Insert. Available at: [accessed August 2013].
-
Teflaro® Package Insert 2012. Available at: [accessed August 2013]. http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/200327s009lbl.pdf.
-
(2012)
-
-
-
2
-
-
84897613107
-
-
European Medicines Assessment Report for Zinforo (ceftaroline fosamil) Procedure No. EMEA/H/C/002252.
-
European Medicines Assessment Report for Zinforo (ceftaroline fosamil) Procedure No. EMEA/H/C/002252.
-
-
-
-
3
-
-
79954622204
-
Review of ceftaroline fosamil microbiology: integrated FOCUS studies
-
iii45-iii51
-
Critchley I.A., Eckburg P.B., Jandourek A., Biek D., Friedland H.D., Thye D.A. Review of ceftaroline fosamil microbiology: integrated FOCUS studies. J Antimicrob Chemother 2011, 66(Suppl. 3):iii45-iii51.
-
(2011)
J Antimicrob Chemother
, vol.66
, Issue.SUPPL. 3
-
-
Critchley, I.A.1
Eckburg, P.B.2
Jandourek, A.3
Biek, D.4
Friedland, H.D.5
Thye, D.A.6
-
4
-
-
79954568574
-
Integrated safety summary of FOCUS 1 and FOCUS 2 trials: Phase III randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with community-acquired pneumonia
-
iii53-iii59
-
Rank D.R., Friedland H.D., Laudano J.B. Integrated safety summary of FOCUS 1 and FOCUS 2 trials: Phase III randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with community-acquired pneumonia. J Antimicrob Chemother 2011, 66:iii53-iii59.
-
(2011)
J Antimicrob Chemother
, vol.66
-
-
Rank, D.R.1
Friedland, H.D.2
Laudano, J.B.3
-
5
-
-
78649489951
-
CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections
-
iv41-iv51
-
Corey G.R., Wilcox M.H., Talbot G.H. CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections. J Antimicrob Chemother 2010, 65(Suppl. 4):iv41-iv51.
-
(2010)
J Antimicrob Chemother
, vol.65
, Issue.SUPPL. 4
-
-
Corey, G.R.1
Wilcox, M.H.2
Talbot, G.H.3
-
6
-
-
77955957827
-
Integrated analysis of CANVAS 1 and 2: Phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection
-
Corey G.R., Wilcox M., Talbot G.H., et al. Integrated analysis of CANVAS 1 and 2: Phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection. Clin Infect Dis 2010, 51:641-650.
-
(2010)
Clin Infect Dis
, vol.51
, pp. 641-650
-
-
Corey, G.R.1
Wilcox, M.2
Talbot, G.H.3
-
7
-
-
78649452602
-
Ceftaroline fosamil: a novel broad-spectrum cephalosporin with expanded anti-Gram-positive activity
-
iv9-iv16
-
Biek D., Critchley I.A., Riccobene T.A., Thye D.A. Ceftaroline fosamil: a novel broad-spectrum cephalosporin with expanded anti-Gram-positive activity. J Antimicrob Chemother 2010, 65(Suppl. 4):iv9-iv16.
-
(2010)
J Antimicrob Chemother
, vol.65
, Issue.SUPPL. 4
-
-
Biek, D.1
Critchley, I.A.2
Riccobene, T.A.3
Thye, D.A.4
-
8
-
-
79954581843
-
Ceftaroline fosamil: a new broad-spectrum cephalosporin
-
iii11-iii18
-
Laudano J.B. Ceftaroline fosamil: a new broad-spectrum cephalosporin. J Antimicrob Chemother 2011, 66(Suppl. 3):iii11-iii18.
-
(2011)
J Antimicrob Chemother
, vol.66
, Issue.SUPPL. 3
-
-
Laudano, J.B.1
-
9
-
-
79954578994
-
Comparative ceftaroline activity tested against pathogens associated with community-acquired pneumonia: results from an international surveillance study
-
iii69-iii80
-
Jones R.N., Farrell D.J., Mendes R.E., Sader H.S. Comparative ceftaroline activity tested against pathogens associated with community-acquired pneumonia: results from an international surveillance study. J Antimicrob Chemother 2011, 66(Suppl. 3):iii69-iii80.
-
(2011)
J Antimicrob Chemother
, vol.66
, Issue.SUPPL. 3
-
-
Jones, R.N.1
Farrell, D.J.2
Mendes, R.E.3
Sader, H.S.4
-
10
-
-
84861162170
-
Summary of ceftaroline activity against pathogens in the United States, 2010: report from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) Surveillance Program
-
Flamm R.K., Sader H.S., Farrell D.J., Jones R.N. Summary of ceftaroline activity against pathogens in the United States, 2010: report from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) Surveillance Program. Antimicrob Agents Chemother 2012, 56:2933-2940.
-
(2012)
Antimicrob Agents Chemother
, vol.56
, pp. 2933-2940
-
-
Flamm, R.K.1
Sader, H.S.2
Farrell, D.J.3
Jones, R.N.4
-
11
-
-
84865246903
-
In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE surveillance program (2008-2010)
-
Farrell D.J., Castanheira M., Mendes R.E., Sader H.S., Jones R.N. In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE surveillance program (2008-2010). Clin Infect Dis 2012, 55(Suppl. 3):S206-S214.
-
(2012)
Clin Infect Dis
, vol.55
, Issue.SUPPL. 3
-
-
Farrell, D.J.1
Castanheira, M.2
Mendes, R.E.3
Sader, H.S.4
Jones, R.N.5
-
12
-
-
84865210377
-
AWARE ceftaroline surveillance program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States
-
Pfaller M.A., Farrell D.J., Sader H.S., Jones R.N. AWARE ceftaroline surveillance program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States. Clin Infect Dis 2012, 55(Suppl. 3):S187-S193.
-
(2012)
Clin Infect Dis
, vol.55
, Issue.SUPPL. 3
-
-
Pfaller, M.A.1
Farrell, D.J.2
Sader, H.S.3
Jones, R.N.4
-
13
-
-
84865218844
-
Activity analyses of staphylococcal isolates from pediatric, adult and elderly patients: AWARE ceftaroline surveillance program
-
Sader H.S., Flamm R.K., Farrell D.J., Jones R.N. Activity analyses of staphylococcal isolates from pediatric, adult and elderly patients: AWARE ceftaroline surveillance program. Clin Infect Dis 2012, 55(Suppl. 3):S181-S186.
-
(2012)
Clin Infect Dis
, vol.55
, Issue.SUPPL. 3
-
-
Sader, H.S.1
Flamm, R.K.2
Farrell, D.J.3
Jones, R.N.4
-
17
-
-
84897671375
-
-
Tygacil Package Insert. 2011. Wyeth Pharmaceuticals. Available at: [accessed January 2013].
-
Tygacil Package Insert. 2011. Wyeth Pharmaceuticals. Available at: [accessed January 2013]. http://www.tygacil.com/.
-
-
-
-
18
-
-
79956304769
-
In vitro activity of ceftaroline against Gram-positive and Gram-negative pathogens isolated from patients attending Canadian hospitals in 2009
-
Karlowsky J.A., Adam H.J., Decorby M.R., Lagace-Wiens P.R., Hoban D.J., Zhanel G.G. In vitro activity of ceftaroline against Gram-positive and Gram-negative pathogens isolated from patients attending Canadian hospitals in 2009. Antimicrob Agents Chemother 2011, 55:2837-2846.
-
(2011)
Antimicrob Agents Chemother
, vol.55
, pp. 2837-2846
-
-
Karlowsky, J.A.1
Adam, H.J.2
Decorby, M.R.3
Lagace-Wiens, P.R.4
Hoban, D.J.5
Zhanel, G.G.6
-
19
-
-
84875372745
-
Spectrum and potency of ceftaroline tested against leading pathogens causing skin and soft-tissue infections in Europe (2010)
-
Farrell D.J., Flamm R.K., Sader H.S., Jones R.N. Spectrum and potency of ceftaroline tested against leading pathogens causing skin and soft-tissue infections in Europe (2010). Int J Antimicrob Agents 2013, 41:337-342.
-
(2013)
Int J Antimicrob Agents
, vol.41
, pp. 337-342
-
-
Farrell, D.J.1
Flamm, R.K.2
Sader, H.S.3
Jones, R.N.4
-
20
-
-
84879953414
-
Ceftaroline fosamil: a review of its use in the treatment of complicated skin and soft tissue infections and community-acquired pneumonia
-
Frampton J.E. Ceftaroline fosamil: a review of its use in the treatment of complicated skin and soft tissue infections and community-acquired pneumonia. Drugs 2013, 73:1067-1094.
-
(2013)
Drugs
, vol.73
, pp. 1067-1094
-
-
Frampton, J.E.1
-
21
-
-
84865424472
-
Activity of ceftaroline-avibactam tested against gram-negative organism populations, including strains expressing one or more beta-lactamases and methicillin-resistant Staphylococcus aureus carrying various SCCmec types
-
Castanheira M., Sader H.S., Farrell D.J., Mendes R.E., Jones R.N. Activity of ceftaroline-avibactam tested against gram-negative organism populations, including strains expressing one or more beta-lactamases and methicillin-resistant Staphylococcus aureus carrying various SCCmec types. Antimicrob Agents Chemother 2012, 56:4779-4785.
-
(2012)
Antimicrob Agents Chemother
, vol.56
, pp. 4779-4785
-
-
Castanheira, M.1
Sader, H.S.2
Farrell, D.J.3
Mendes, R.E.4
Jones, R.N.5
-
22
-
-
77953479908
-
Evolution of methicillin-resistant Staphylococcus aureus clones in Latin America
-
Rodriguez-Noriega E., Seas C., Guzman-Blanco M., et al. Evolution of methicillin-resistant Staphylococcus aureus clones in Latin America. Int J Infect Dis 2010, 14:e560-e566.
-
(2010)
Int J Infect Dis
, vol.14
-
-
Rodriguez-Noriega, E.1
Seas, C.2
Guzman-Blanco, M.3
|